Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study.

Gerber B, von Minckwitz G, Stehle H, Reimer T, Felberbaum R, Maass N, Fischer D, Sommer HL, Conrad B, Ortmann O, Fehm T, Rezai M, Mehta K, Loibl S; German Breast Group Investigators.

J Clin Oncol. 2011 Jun 10;29(17):2334-41. doi: 10.1200/JCO.2010.32.5704. Epub 2011 May 2.

PMID:
21537042
2.

Cancer statistics, 2010.

Jemal A, Siegel R, Xu J, Ward E.

CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7. Erratum in: CA Cancer J Clin. 2011 Mar-Apr;61(2):133-4.

3.

Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study.

Sukumvanich P, Case LD, Van Zee K, Singletary SE, Paskett ED, Petrek JA, Naftalis E, Naughton MJ.

Cancer. 2010 Jul 1;116(13):3102-11. doi: 10.1002/cncr.25106.

4.

Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.

Swain SM, Jeong JH, Geyer CE Jr, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff J, Vogel VG, Erban JK, Rastogi P, Livingston RB, Perez EA, Mamounas EP, Land SR, Ganz PA, Wolmark N.

N Engl J Med. 2010 Jun 3;362(22):2053-65. doi: 10.1056/NEJMoa0909638.

5.

Fertility preservation in adolescents and young adults with cancer.

Levine J, Canada A, Stern CJ.

J Clin Oncol. 2010 Nov 10;28(32):4831-41. doi: 10.1200/JCO.2009.22.8312. Epub 2010 May 10. Review.

PMID:
20458029
6.

Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated with gonadotropin after pituitary suppression.

Peñarrubia J, Peralta S, Fábregues F, Carmona F, Casamitjana R, Balasch J.

Fertil Steril. 2010 Dec;94(7):2590-5. doi: 10.1016/j.fertnstert.2010.03.009. Epub 2010 Apr 18.

PMID:
20400077
7.

Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles.

Sowers M, McConnell D, Gast K, Zheng H, Nan B, McCarthy JD, Randolph JF.

Fertil Steril. 2010 Sep;94(4):1482-6. doi: 10.1016/j.fertnstert.2009.07.1674. Epub 2009 Dec 6.

8.

Women's health, breast health: a review of the gynecologic effects of breast cancer.

Goldman M, O'Hair K.

Obstet Gynecol Surv. 2009 Jul;64(7):469-80; quiz 499. doi: 10.1097/OGX.0b013e3181a713f1. Review.

PMID:
19545455
9.

Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC).

Urruticoechea A, Arnedos M, Walsh G, Dowsett M, Smith IE.

Breast Cancer Res Treat. 2008 Aug;110(3):411-6. Epub 2007 Sep 13.

PMID:
17851753
10.

Spontaneous pregnancy and normal delivery after repeated autologous bone marrow transplantation and GnRH agonist treatment.

Blumenfeld Z, Benaroush M, Zuckerman T.

Hum Reprod. 2007 Aug;22(8):2346. Epub 2007 Apr 23. No abstract available. Erratum in: Hum Reprod. 2007 Oct;22(10):2799. Blumenfeld, Zeev [added]; Benaroush, Miriam [added].

PMID:
17452395
11.

The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane.

Tham YL, Sexton K, Weiss H, Elledge R, Friedman LC, Kramer R.

Am J Clin Oncol. 2007 Apr;30(2):126-32.

PMID:
17414460
12.

American Society of Clinical Oncology recommendations on fertility preservation in cancer patients.

Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K; American Society of Clinical Oncology.

J Clin Oncol. 2006 Jun 20;24(18):2917-31. Epub 2006 May 1. Erratum in: J Clin Oncol. 2006 Dec 20;24(36):5790.

PMID:
16651642
13.

Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study.

Petrek JA, Naughton MJ, Case LD, Paskett ED, Naftalis EZ, Singletary SE, Sukumvanich P.

J Clin Oncol. 2006 Mar 1;24(7):1045-51. Epub 2006 Feb 13.

PMID:
16476708
14.
15.

Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment: the effect of the addition of taxanes.

Davis AL, Klitus M, Mintzer DM.

Clin Breast Cancer. 2005 Dec;6(5):421-4.

PMID:
16381625
16.

Modelling menstrual status during and after adjuvant treatment for breast cancer.

Szwarc SE, Bonetti M.

Stat Med. 2006 Oct 30;25(20):3534-47.

PMID:
16345025
17.

Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients.

Del Mastro L, Catzeddu T, Boni L, Bell C, Sertoli MR, Bighin C, Clavarezza M, Testa D, Venturini M.

Ann Oncol. 2006 Jan;17(1):74-8. Epub 2005 Oct 27.

PMID:
16254024
18.
19.

Potential options for preservation of fertility in women.

Lobo RA.

N Engl J Med. 2005 Jul 7;353(1):64-73. Review. No abstract available.

PMID:
16000356
20.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG).

Lancet. 2005 May 14-20;365(9472):1687-717.

PMID:
15894097

Supplemental Content

Support Center